Extensively Drug-Resistant Tuberculosis in South Korea: Risk Factors and Treatment Outcomes among Patients at a Tertiary Referral Hospital
Open Access
- 1 January 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (1) , 42-49
- https://doi.org/10.1086/524017
Abstract
Background. Extensively drug‐resistant (XDR) tuberculosis (TB) is a major public health threat in South Korea.Methods. We analyzed baseline epidemiolKeywords
This publication has 9 references indexed in Scilit:
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaPublished by Elsevier ,2006
- Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areasThorax, 2006
- Extensively Drug‐Resistant Tuberculosis: 2 Years of Surveillance in IranClinical Infectious Diseases, 2006
- Antibiotic use following a Korean national policy to prohibit medication dispensing by physiciansHealth Policy and Planning, 2005
- Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort studyThe Lancet, 2005
- DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently neededTuberculosis, 2003
- In Vitro Activities of Fourteen Antimicrobial Agents Against Drug Susceptible and Resistant Clinical Isolates of Mycobacterium tuberculosis and Comparative Intracellular Activities Against the Virulent H37Rv Strain in Human MacrophagesCurrent Microbiology, 1996
- Clinical Pharmacokinetics of the Antituberculosis DrugsClinical Pharmacokinetics, 1984
- Pharmacokinetics of Aminoglycosides in Subjects with Normal and Impaired Renal FunctionPublished by S. Karger AG ,1977